Journal article
Blood DNA methylation as a potential biomarker of dementia: A systematic review
PD Fransquet, P Lacaze, R Saffery, J McNeil, R Woods, J Ryan
Alzheimer S and Dementia | WILEY | Published : 2018
Abstract
Dementia is a major public health issue with rising prevalence rates, but many individuals remain undiagnosed. Accurate and timely diagnosis is key for the optimal targeting of interventions. A noninvasive, easily measurable peripheral biomarker would have greatest utility in population-wide diagnostic screening. Epigenetics, including DNA methylation, is implicated in dementia; however, it is unclear whether epigenetic changes can be detected in peripheral tissue. This study aimed to systematically review the evidence for an association between dementia and peripheral DNA methylation. Forty-eight studies that measured DNA methylation in peripheral blood were identified, and 67% reported sig..
View full abstractGrants
Awarded by National Institute on Aging
Funding Acknowledgements
P.F. is funded by RTP stipend PhD scholarship, awarded by Monash University and the Australian Government. The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and decision to submit the article for publication.